Sun.Feb 25, 2024

article thumbnail

Rare Disease Day 2024 – The importance of shining a light on rare diseases

pharmaphorum

Rare Disease Day 2024 is an important opportunity to raise awareness about rare diseases and the need for research, diagnosis, and treatment options like orphan drugs. Learn the significance of shining a light on rare diseases.

114
114
article thumbnail

API industry is seeing robust action in leadership hiring space: Report

Express Pharma

For this report WalkWater researched 51 API companies and included 120 candidates at leadership level in manufacturing role WalkWater Talent Advisors, one of India’s top executive search firms has released a comprehensive report shedding light on key trends and talent insights which are driving leadership hiring in the manufacturing function in India’s Active Pharmaceutical Ingredient (API) industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CymaBay's seladelpar has the potential to raise the bar in treatment for PBC

Outsourcing Pharma

Results from a phase 3 trial looking at treatment for primary biliary cholangitis (PBC) are 'genuinely exciting' and supports the potential for seladelpar to raise the bar in treatment of the disease.

94
article thumbnail

Cadila Pharma launches aqueous vitamin D injection

Express Pharma

Aqueous cholecalciferol injection offers a unique solution with rapid correction of vitamin D deficiency in a short span of time Cadila Pharma has announced the launch of the world’s first aqueous formulation of cholecalciferol for v itamin D deficiency. This innovation demonstrates superior pharmacokinetics (PK) and pharmacodynamics (PD) compared to traditional oil-based cholecalciferol preparations available in the market.

103
103
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Which pharmaceutical companies have the most drug patents in Serbia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Serbia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Serbia? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Interchangeable high-concentration Humira approved in US

pharmaphorum

TevaU and Alvotech claim first US approval for first biosimilar of AbbVie’s high-concentration Humira, which accounts for 88% of brand prescriptions

More Trending

article thumbnail

New patent expiration for Endo Pharms drug NASCOBAL

Drug Patent Watch

Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier.… The post New patent expiration for Endo Pharms drug NASCOBAL appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Health Canada disclosing more information on pending generic drug submissions

Pharma in Brief

On February 23, 2024, Health Canada published a Notice advising that it was making its review process for generic drug submissions more transparent. Specifically, for generic drug submissions accepted into review on or after April 1, 2024, Health Canada will start disclosing: (i) the year and month that the submission was accepted for review; and (ii) the company sponsoring the generic drug.

article thumbnail

New patent expiration for Almatica drug GRALISE

Drug Patent Watch

Annual Drug Patent Expirations for GRALISE Gralise is a drug marketed by Almatica and is included in one NDA. It is available from one supplier. There is one patent protecting… The post New patent expiration for Almatica drug GRALISE appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Free NAPLEX Osteoporosis Crossword Puzzle

Med Ed 101

I’m currently working on finishing up a big-time project for the NAPLEX exam. It is a crossword puzzle book that will help prepare you for the NAPLEX. I’m providing a free osteoporosis crossword puzzle as a sample of what this book will be like. There will be 100 puzzles and well over 2,000 practice questions […] The post Free NAPLEX Osteoporosis Crossword Puzzle appeared first on Med Ed 101.

52
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Episode 899: Glucocorticoids Have No Role Reversing the Acute Symptoms of Anaphylaxis. Here’s Why:

Pharmacy Joe

In this episode, I’ll discuss why glucocorticoids have no role in reversing the acute symptoms of anaphylaxis. Episode 899: Glucocorticoids Have No Role Reversing the Acute Symptoms of Anaphylaxis. Here's Why: Subscribe on iTunes , Android , or Stitcher Despite epinephrine clearly being recommended as the first line of treatment for an acute episode of anaphylaxis, glucocorticoids continue to be given by many providers.

article thumbnail

Microbiology Laboratory Strategies to Advance Antimicrobial Stewardship

ID Stewardship

In this article four experts from bioMérieux discuss microbiology strategies to advance antimicrobial stewardship, reflecting on a recent Xchat (Twitter Chat) on the topic. Authored By: Katarzyna Wojcik, PMP, PhD, Andrea Prinzi, PhD, MPH, CPH, SM(ASCP), Amanda Suchanek, Ph.D., Jessica Blavignac There is no question that antimicrobial resistance (AMR) has created new challenges for all stakeholders, requiring active and continued collaboration between healthcare professionals and various discip